Views on electronic cigarette use in tobacco screening and cessation in an Alaska Native healthcare setting

Figures & data

Table I. Participant characteristics

	Customer–owners	Leaders	Providers	All participants
Gender
Female	14	9	10	33
Male	6	0	3	9
Age
18–29 years old	7	1	0	8
30–39 years old	1	4	5	10
40–59 years old	9	4	8	21
60+ years old	3	0	0	3
Highest level education completed
> High school	0	0	0	0
High school graduate	4	0	1	5
Some college	9	1	0	10
College graduate	3	5	10	18
Trade or vocational school	0	2	2	4
Past quit attempt (any type of tobacco)?
Yes	16	5	5	26
No	4	4	8	16

Table II. Interview guide

Interview questions	Customer–owners	Leaders	Providers
Views on tobacco use, consequences, and cessation
When did you start smoking or chewing? Has your tobacco use changed over time?	X
Why do people use tobacco, in your view?	X	X	X
How does using tobacco affect a person's health and wellbeing, for better or worse?	X	X	X
What are the advantages and disadvantages of quitting tobacco?	X	X	X
Experience with tobacco use and cessation at SCF
Could you share your personal tobacco story with me?	X
What is your experience with quitting tobacco?	X
Can you tell me how Southcentral Foundation (SCF) currently approaches tobacco use and cessation with customer owners?		X	X
In your experience, which tobacco cessation approaches are most useful/successful? Why do you think that is?			X
How do you approach tobacco use and tobacco cessation with customer–owners?			X
What questions do customer–owners tend to ask about tobacco cessation?			X
Views on using pharmacogenetic testing for tobacco cessation at SCF
What comes to mind when you think about the phrase “genetic testing?”	X	X
How do you feel about the use of genetic tests in your practice?			X
Let's say SCF wanted to participant in research that included genetic tests to understand how people respond differently to medications used for quitting tobacco – what would you think about that?	X	X	X
If SCF did this kind of research, would you participate? Why or why not? What questions would you have about it? What would you want to know about it?	X
If SCF did this kind of research, how would you feel about your customer–owners participating?			X
What would you like your customers to know about genetic testing?		X	X
If a genetic test became available to help people choose the best medication for quitting tobacco, should SCF offer it? Why or why not?	X	X	X
If you had a customer–owner that was trying to quit tobacco and SCF offered a genetic test to guide your medication choice, would you order the test?			X
If you were trying to quit tobacco and SCF offered a genetic test to guide your medication choice, would you want to have the test? Why or why not? What other information would help you decide?	X
How do you think customer–owners would respond to the use of genetic testing at SCF to guide tobacco cessation treatment?			X
Concluding remarks
What else should we know about this topic?	X	X	X
How was this interview for you?	X	X	X

Many questions reworded to suite the role of the participant. Question follow-up probes were removed from interview guide for brevity.